ArticleFrontiers in immunology2022

Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern.

Steven Y Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.